Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Training Courses – Full Topics Checkboxes
Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Back to Filter ^

Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective

Format: Webinar
The current opioid and drug overdose crisis continues to have a devastating impact on morbidity and mortality in the United States. With the rise in use of potent synthetic opioids like fentanyl in the drug supply, creating linkages to comprehensive substance use related services is critical. Opioid Treatment Programs (OTP) and the comprehensive care and services they provide play a vital role in addressing this need, yet challenges remain. Despite clear evidence of the benefits of OTP’s, access to OTPs in some parts of the country is limited; stigma related to the use of methadone remains a challenge. Yet in the face of these headwinds, many OTPs are providing comprehensive leading-edge services to address the opioid and drug overdose crisis.
Target Audience(s):
Interprofessional Teams, Administrative Staff, Family and Patient, Nurses, PAs, Physicians, Psychiatrists, Psychologists, Social Workers, Students and Educators
Topic(s):
Co-Occurring SUD / Medical Disorders, Access / Disparities, Agonist / Partial Agonist Withdrawal, Antagonist, Buprenorphine, Buprenorphine, Chronic Disease Model, Chronic Pain, Co-Occurring Addiction / Psychiatric, Continuum of Care ...
Presenter(s):
Mark Parrino, President & CEO of The American Association for the Treatment of Opioid Dependence, Inc. and Jennifer Seib, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Organizer(s):
National Council for Mental Wellbeing

Treatment of Acute Pain in Patients Receiving Buprenorphine/Naloxone

Format: Clinical Tool
How do I manage acute pain in a patient receiving buprenorphine/naloxone (bup/nx; Suboxone, Zubsolv) for the treatment of opioid dependence?
Target Audience(s):
Nurses, PAs, Pharmacists, Physicians, Psychiatrists
Topic(s):
Co-Occurring SUD / Medical Disorders, Acute Pain, Buprenorphine, General Medical Comorbidities, Medications, Opioids, Opioids, Pain, Setting, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No

Buprenorphine Induction

Format: Clinical Tool
Buprenorphine induction, performed at the right time, remains one of the most satisfying procedures a patient and his/her physician can experience. While there may be initial fears or concerns about precipitating withdrawal, if the patient presents with objective signs of withdrawal and doses are slowly titrated upwards, the patient will leave the office much happier than he/she has been in a long time. The physician will see immediate positive results — a rare occurrence in clinical practice.
Target Audience(s):
Nurses, PAs, Pharmacists, Physicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Pharmacology, Agonist / Partial Agonist Withdrawal, Buprenorphine, Buprenorphine, Medications, Opioids, Opioids, Opioids, Partial Agonists, Treatment ...
Credit Available:
CE Credit(s): No
Certificate: No

Medically Supervised Withdrawal Followed by Complete Abstinence

Format: Clinical Tool
When scientists try to find new ways to help patients recover from physical dependence on opioids, they look for treatments that are both safe and effective.
Target Audience(s):
Physicians, Family and Patient, Nurses, PAs, Pharmacists, Pharmacy Technicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Treatment, Agonist / Partial Agonist Withdrawal, Buprenorphine, Medications, Methadone, Naltrexone, Opioids, Opioids, Symptomatic Management, Transition to MOUD ...
Credit Available:
CE Credit(s): No
Certificate: No

TIP 63: Medications for Opioid Use Disorder

Format: Clinical Tool
This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat opioid use disorder (OUD)—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD.
Target Audience(s):
Dentists, Interprofessional Teams, Nurses, PAs, Pharmacists, Physicians, Psychiatrists, Psychologists, Social Workers
Topic(s):
Treatment, Agonist / Partial Agonist Withdrawal, Antagonist, Buprenorphine, Buprenorphine, Full Agonists, Medications, Methadone, Methadone, Naltrexone ...
Credit Available:
CE Credit(s): No
Certificate: No
Organizer(s):
Substance Abuse and Mental Health Services Administration

Opioid Withdrawal

Format: Clinical Tool
n a person decides to stop or reduce his or her use of an opioid drug that he/she has been using in large amounts over a long period of time, the person will experience withdrawal. Withdrawal consists of many different painful symptoms that occur as opioid levels in the body decrease.
Target Audience(s):
Family and Patient
Topic(s):
Withdrawal Management, Opioids ...
Credit Available:
CE Credit(s): No
Certificate: No
More Results